Edition:
India

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

3.70USD
20 Mar 2019
Change (% chg)

$0.04 (+1.09%)
Prev Close
$3.66
Open
$3.66
Day's High
$3.81
Day's Low
$3.63
Volume
14,654
Avg. Vol
28,083
52-wk High
$6.70
52-wk Low
$2.75

Latest Key Developments (Source: Significant Developments)

Harvard Bioscience Reports Fourth Quarter Results
Friday, 1 Mar 2019 

Feb 28 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE REPORTS STRONG FOURTH QUARTER AND YEAR-END 2018 RESULTS, AND ISSUES 2019 FINANCIAL GUIDANCE.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $0.21 TO $0.23.SEES FY 2019 GAAP EARNINGS PER SHARE ABOUT $0.03 TO $0.05.Q4 NON-GAAP EARNINGS PER SHARE $0.07.Q4 EARNINGS PER SHARE ESTIMATE $0.07 -- REFINITIV IBES DATA.Q4 GAAP EARNINGS PER SHARE $0.06.SEES FY 2019 REVENUE $124 MILLION TO $126.5 MILLION.Q4 REVENUE $33.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF $32.2 MILLION.  Full Article

Harvard Bioscience Names Kam Unninayar As CFO
Tuesday, 23 Oct 2018 

Oct 22 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE NAMES KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER.HARVARD BIOSCIENCE NAMES KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER.APPOINTED KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER, EFFECTIVE NOVEMBER 26, 2018.UNNINAYAR REPLACES ROBERT GAGNON, WHO RESIGNED POSITION OF CFO EFFECTIVE AUG 31, 2018.  Full Article

Harvard Bioscience CFO Resigns
Wednesday, 22 Aug 2018 

Aug 22 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE ANNOUNCES MANAGEMENT CHANGE.COMPANY HAS INITIATED A SEARCH FOR ITS NEXT CHIEF FINANCIAL OFFICER.ANNOUNCED RESIGNATION OF ROBERT E. GAGNON, CHIEF FINANCIAL OFFICER, EFFECTIVE AUGUST 31, 2018.  Full Article

Harvard Bioscience Q2 Non-Gaap Earnings Per Share $0.07
Friday, 27 Jul 2018 

July 26 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.SEES FY 2018 NON-GAAP EARNINGS PER SHARE ABOUT $0.20 TO $0.23.SEES FY 2018 GAAP LOSS PER SHARE ABOUT $0.12 TO $0.15.Q2 NON-GAAP EARNINGS PER SHARE $0.07.Q2 EARNINGS PER SHARE VIEW $0.05 -- THOMSON REUTERS I/B/E/S.Q2 GAAP LOSS PER SHARE $0.04.Q2 REVENUE $31.5 MILLION VERSUS I/B/E/S VIEW $30.7 MILLION.REAFFIRMING ITS NON-GAAP FINANCIAL GUIDANCE FOR FULL YEAR 2018.  Full Article

Harvard Bioscience Inc Files For Mixed Shelf Of Up To $50 Mln
Tuesday, 1 May 2018 

April 30 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING.  Full Article

Harvard Bioscience Says Co Entered Into A Financing Agreement
Saturday, 3 Feb 2018 

Feb 2 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE INC - ON JAN 31, 2018, CO ENTERED INTO A FINANCING AGREEMENT - SEC FILING.HARVARD BIOSCIENCE INC - FINANCING AGREEMENT PROVIDES SENIOR SECURED CREDIT FACILITIES HAVING $64 MILLION TERM LOAN, $25 MILLION REVOLVING CREDIT LINE.  Full Article

Harvard Bioscience reports Q3 loss $0.01/shr
Friday, 27 Oct 2017 

Oct 26 (Reuters) - Harvard Bioscience Inc :Harvard Bioscience reports third quarter 2017 financial results.Sees Q4 2017 non-GAAP earnings per share $0.05 to $0.06.Sees Q4 2017 GAAP loss per share about $0.00 to $0.01.Q3 revenue $25.1 million versus i/b/e/s view $24.6 million.Q3 non-GAAP earnings per share $0.03.Q3 GAAP loss per share $0.01.Q3 earnings per share view $0.03 -- Thomson Reuters I/B/E/S.Harvard Bioscience Inc - ‍reaffirming its Q4 revenue guidance​.  Full Article